Changing Market Dynamics of Cytomegalovirus Infections Market in the 7 Major Markets

 Breaking News
  • No posts were found

Changing Market Dynamics of Cytomegalovirus Infections Market in the 7 Major Markets

April 19
19:16 2021
Changing Market Dynamics of Cytomegalovirus Infections Market in the 7 Major Markets

Cytomegalovirus Infections Market” report has been added to DelveInsight

The Cytomegalovirus Infections Market report provides an edge while developing business strategies, by understanding trends shaping and driving the global Cytomegalovirus Infections Market

Download free sample copy here- https://www.delveinsight.com/sample-request/cytomegalovirus-cmv-infection-market-insight-epidemiology-and-market-forecast

Cytomegalovirus Infections Overview

Infection with cytomegalovirus (CMV) is very common. CMV Infections is a type of herpesvirus (herpesvirus type 5). Blood tests show that 60–90% of adults have had a CMV Infections infection at some time. Infections infection at some time. CMV Infections may cause symptoms soon after infection and can also remain dormant (inactive) in various tissues for life. Various stimuli can reactivate the dormant CMV Infections, resulting in virus growth which can sometimes cause disease. The lungs, gastrointestinal tract, brain, spinal cord, or eyes may be infected.

Cytomegalovirus Infections Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Cytomegalovirus Infections Key Players

  • Roche
  • Clinigen Group plc
  • CSL Behring
  • Takeda/Shire Pharmaceuticals
  • Helocyte
  • AlloVir
  • Merck
  • ModernaTX
  • Hookipa Biotech

Cytomegalovirus Infections Drugs

  • Valcyte
  • Foscavir
  • CytoGam
  • Maribavir (TAK-602)
  • Triplex
  • Viralym-M
  • V160
  • mRNA-1647
  • HB101

Cytomegalovirus Infections Report Key Strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Epidemiology Segmentation
  • Drugs Uptake
  • Highly Analyzed Market
  • Key Cross Competition

Cytomegalovirus Infections Market Report

When a baby is born with cytomegalovirus (CMV Infections) infection, it is called congenital CMV Infections. Most babies with congenital CMV Infections never show signs or have health problems. However, some babies have health problems at birth or that develop later. When the infection threatens life or eyesight, an antiviral drug (valganciclovir, ganciclovir, cidofovir, foscarnet, or a combination) may be given. These drugs may be given by mouth or by vein. When CMV Infections retinitis is very severe, the drugs may also be injected directly into the eye. These drugs have serious side effects, which increase the demand and need for more potential therapies. The market is expected to grow by factors like an increase in the patient pool, expected entry of emerging therapies, i.e., such as V160, mRNA-1647, HB-101, and deeper penetration in the United states markets.

Cytomegalovirus Infections Market Outlook

According to DelveInsight, the market of Cytomegalovirus (CMV) Infections in 7MM was found to be approximately USD 1195.10 million in 2017. Cytomegalovirus (CMV) Infections market size in the United States accounted for approx. 68.16% of the total market in 2017.

Among the EU5 countries, in 2017, France had the highest market size with approximately USD 84.00 million, while Italy had the lowest market size for CMV Infection with approximately USD 47.00 million.

The market size of prophylactic and therapeutic CMV Infection in seven major markets was approximately USD 771.00 million and 423.00 million in 2017.

Download free sample copy here- https://www.delveinsight.com/sample-request/cytomegalovirus-cmv-infection-market-insight-epidemiology-and-market-forecast

Following is the TOC of Cytomegalovirus Infections market report

1. Key Insight

2. Cytomegalovirus (CMV) Infections: Market Overview at a Glance

3. Disease Background and Overview: Cytomegalovirus Infections (CMV)

4. Epidemiology and Patient Population

6. Treatment Algorithm

7. Unmet Needs

8. Marketed Products

9. Emerging Drugs

10. Failed Therapies

11. Cytomegalovirus Infection: 7 Major Market Analysis

12. The United States Market Outlook

13. EU-5 Countries: Market Outlook

14. Market Drivers

15. Market Barriers

16. Appendix

17. DelveInsight Capabilities

18. Disclaimer

19. About DelveInsight


Related Reports

Cytomegalovirus Infection Epidemiology

DelveInsight’s Cytomegalovirus Infection Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Cytomegalovirus (CMV) Infection in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Cytomegalovirus Infection Pipeline

Cytomegalovirus (CMV) Infection Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Cytomegalovirus (CMV) Infection market.



Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Vinita Rakheja
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: www.delveinsight.com/